Sodium Butyrate Stimulates Expression of Fibroblast Growth Factor 21 in Liver by Inhibition of Histone Deacetylase 3

Fibroblast growth factor 21 (FGF21) stimulates fatty acid oxidation and ketone body production in animals. In this study, we investigated the role of FGF21 in the metabolic activity of sodium butyrate, a dietary histone deacetylase (HDAC) inhibitor. FGF21 expression was examined in serum and liver after injection of sodium butyrate into dietary obese C57BL/6J mice. The role of FGF21 was determined using antibody neutralization or knockout mice. FGF21 transcription was investigated in liver and HepG2 hepatocytes. Trichostatin A (TSA) was used in the control as an HDAC inhibitor. Butyrate was compared with bezafibrate and fenofibrate in the induction of FGF21 expression. Butyrate induced FGF21 in the serum, enhanced fatty acid oxidation in mice, and stimulated ketone body production in liver. The butyrate activity was significantly reduced by the FGF21 antibody or gene knockout. Butyrate induced FGF21 gene expression in liver and hepatocytes by inhibiting HDAC3, which suppresses peroxisome proliferator–activated receptor-α function. Butyrate enhanced bezafibrate activity in the induction of FGF21. TSA exhibited a similar set of activities to butyrate. FGF21 mediates the butyrate activity to increase fatty acid use and ketogenesis. Butyrate induces FGF21 transcription by inhibition of HDAC3.

• Publication year

  2012

• Venue

  Diabetes

• Publication date

  2012-03-14

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.2337/db11-0846PMID 22338096PMCID 3314370
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Thiazolidinediones are potent inducers of fibroblast growth factor 21 expression in the liver.

  2011cited by this paper
• Class IIa histone deacetylases are hormone-activated regulators of FOXO and mammalian glucose homeostasis.

  2011cited by this paper
• Circadian rhythm of circulating fibroblast growth factor 21 is related to diurnal changes in fatty acids in humans.

  2011cited by this paper
• FGF21 reloaded: challenges of a rapidly growing field.

  2011cited by this paper
• Thyroid Hormone Regulates Hepatic Expression of Fibroblast Growth Factor 21 in a PPARα-dependent Manner*

  2010cited by this paper
• Effects of the peroxisome proliferator-activated receptor-alpha agonists clofibrate and fish oil on hepatic fatty acid metabolism in weaned dairy calves.

  2010cited by this paper
• Obesity Is a Fibroblast Growth Factor 21 (FGF21)-Resistant State

  2010cited by this paper
• Fibroblast growth factor 21 levels are increased in nonalcoholic fatty liver disease patients and are correlated with hepatic triglyceride.

  2010cited by this paper
• Circulating fibroblast growth factor 21 is induced by peroxisome proliferator-activated receptor agonists but not ketosis in man.

  2009influential reference
• Free Fatty Acids Link Metabolism and Regulation of the Insulin-Sensitizing Fibroblast Growth Factor-21

  2009cited by this paper
• Circulating Fibroblast Growth Factor-21 Is Elevated in Impaired Glucose Tolerance and Type 2 Diabetes and Correlates With Muscle and Hepatic Insulin Resistance

  2009cited by this paper
• Butyrate Improves Insulin Sensitivity and Increases Energy Expenditure in Mice

  2009influential reference
• Fibroblast growth factor 21 regulates lipolysis in white adipose tissue but is not required for ketogenesis and triglyceride clearance in liver.

  2009cited by this paper
• Fibroblast growth factor 21-deficient mice demonstrate impaired adaptation to ketosis.

  2009cited by this paper
• Fibroblast growth factor 21 controls glycemia via regulation of hepatic glucose flux and insulin sensitivity.

  2009cited by this paper
• Serum fibroblast growth factor 21 is associated with adverse lipid profiles and gamma-glutamyltransferase but not insulin sensitivity in Chinese subjects.

  2009cited by this paper
• The circulating metabolic regulator FGF21 is induced by prolonged fasting and PPARalpha activation in man.

  2008cited by this paper
• Liver-Specific Peroxisome Proliferator–Activated Receptor α Target Gene Regulation by the Angiotensin Type 1 Receptor Blocker Telmisartan

  2008cited by this paper
• Serum FGF21 Levels Are Increased in Obesity and Are Independently Associated With the Metabolic Syndrome in Humans

  2008cited by this paper
• Anti-obesity, anti-diabetic, and lipid lowering effects of the thyroid receptor beta subtype selective agonist KB-141.

  2008cited by this paper
• Fibroblast growth factor 21 corrects obesity in mice.

  2008cited by this paper
• PPAR-α agonism improves whole body and muscle mitochondrial fat oxidation, but does not alter intracellular fat concentrations in burn trauma children in a randomized controlled trial

  2007cited by this paper
• Hepatic fibroblast growth factor 21 is regulated by PPARalpha and is a key mediator of hepatic lipid metabolism in ketotic states.

  2007cited by this paper
• Therapeutic potential for thyroid hormone receptor-beta selective agonists for treating obesity, hyperlipidemia and diabetes.

  2007cited by this paper
• Endocrine regulation of the fasting response by PPARalpha-mediated induction of fibroblast growth factor 21.

  2007cited by this paper
• FGF-21 as a novel metabolic regulator.

  2005cited by this paper
• Evolution of the Fgf and Fgfr gene families.

  2004cited by this paper
• Inhibition of histone deacetylase activity by butyrate.

  2003cited by this paper
• Peroxisome proliferator-activated receptor-alpha regulates fatty acid utilization in primary human skeletal muscle cells.

  2002cited by this paper
• Peroxisome Proliferator-Activated Receptor-α Regulates Fatty Acid Utilization in Primary Human Skeletal Muscle Cells

  2002cited by this paper
• Binding of TATA Binding Protein to a Naturally Positioned Nucleosome Is Facilitated by Histone Acetylation

  2001cited by this paper
• Mitochondrial 3-hydroxy-3-methylglutaryl-CoA synthase: a control enzyme in ketogenesis.

  1999cited by this paper
• Flux control exerted by mitochondrial outer membrane carnitine palmitoyltransferase over beta-oxidation, ketogenesis and tricarboxylic acid cycle activity in hepatocytes isolated from rats in different metabolic states.

  1996cited by this paper

• When short-chain fatty acids meet type 2 diabetes mellitus: Revealing mechanisms, envisioning therapies.

  2025cites this paper
• Tagatose consumption provokes metabolic syndrome features in rat males from mothers that consumed fructose during their pregnancy

  2025influential citation
• Epigenetic orchestrator and drug enhancer: dual roles of butyrate in regulating post-translational modification and optimizing therapeutic delivery

  2025cites this paper
• Microbial short chain fatty acids: Effective histone deacetylase inhibitors in immune regulation (Review)

  2025cites this paper
• Nutritional Heterogeneity of Dietary Proteins: Mechanisms of Gut Microbiota-Mediated Metabolic Regulation and Health Implications.

  2025cites this paper
• Research progress on the role of FGF21 in insulin resistance

  2025cites this paper
• Recent advancements and comprehensive analyses of butyric acid in cardiovascular diseases

  2025cites this paper
• Multiomics reveals metformin’s dual role in gut microbiome remodeling and hepatic metabolic reprogramming for MAFLD intervention

  2025cites this paper
• Genetic regulation of short chain fatty acid on Leghorn male hepatoma cells infected with Fowl Adenovirus serotype-4.

  2025cites this paper
• Lactobacillus rhamnosus FSJ13 alleviates pancreatic fibrosis in mice via fibroblast growth factor 21.

  2025cites this paper
• Gestational Inulin Supplementation in Low-/High-Fat Sow Diets: Effects on Growth Performance, Lipid Metabolism, and Meat Quality of Offspring Pigs

  2025influential citation
• Sodium butyrate attenuates liver fibrogenesis via promoting H4K8 crotonylation

  2025cites this paper
• Lactate orchestrates metabolic hemodynamic adaptations through a unique combination of venocontraction, artery relaxation, and positive inotropy

  2025cites this paper
• Sodium butyrate inhibits activation of ROS/NF-κB/NLRP3 signaling pathway and angiogenesis in human retinal microvascular endothelial cells

  2025cites this paper
• Fibroblast growth factor 21 serum levels in diabetes mellitus patients: assessment of their correlation with carbohydrate and lipid metabolism markers

  2025cites this paper
• FGF21 protects against HFpEF by improving cardiac mitochondrial bioenergetics in mice

  2025cites this paper
• Improvements in Exercise for Alzheimer’s Disease: Highlighting FGF21-Induced Cerebrovascular Protection

  2025cites this paper
• Sodium butyrate ameliorates high glucose-suppressed neuronal mitophagy by restoring PRKN expression via inhibiting the RELA-HDAC8 complex

  2024cites this paper
• Short-chain fatty acids: metabolism, functions and diagnostic capacity in metabolic disorders

  2024cites this paper
• Expression of PGC-1α, PPAR-α and UCP1 genes, metabolic and anthropometric factors in response to sodium butyrate supplementation in patients with obesity: a triple-blind, randomized placebo-controlled clinical trial

  2024cites this paper
• Histone deacetylase inhibition enhances extracellular vesicles from muscle to promote osteogenesis via miR-873-3p

  2024cites this paper
• Mechanisms of regulation of glycolipid metabolism by natural compounds in plants: effects on short-chain fatty acids

  2024cites this paper
• FGF21-dependent alleviation of cholestasis-induced liver fibrosis by sodium butyrate

  2024cites this paper
• Gut Microbiota Metabolite Messengers in Brain Function and Pathology at a View of Cell Type-Based Receptor and Enzyme Reaction

  2024cites this paper
• Mechanistic Review on the Role of Gut Microbiota in the Pathology of Cardiovascular Diseases.

  2024cites this paper
• A novel hepatocyte ketone production assay to help the selection of nutrients for the ketogenic diet treatment of epilepsy

  2024influential citation
• Short-Chain Fatty Acids and Human Health: From Metabolic Pathways to Current Therapeutic Implications

  2024cites this paper
• Sucralose and stevia consumption leads to intergenerational alterations in body weight and intestinal expression of histone deacetylase 3.

  2024cites this paper
• Epigenetic Alterations in Alzheimer’s Disease: Impact on Insulin Signaling and Advanced Drug Delivery Systems

  2024cites this paper
• The molecular mechanisms underlying gut microbiota-miRNA interaction in metabolic disorders.

  2024cites this paper
• Regulation of Acetylation States by Nutrients in the Inhibition of Vascular Inflammation and Atherosclerosis

  2023cites this paper
• Butyrate Alleviates High-Fat-Induced Metabolic Disorders Partially through Increasing Systematic Glutamine.

  2023cites this paper
• HDAC Inhibitors: A Novel Approach to Hyperglycaemia Management and Treatment

  2023cites this paper
• Intestinal Microbiotas and Alcoholic Hepatitis: Pathogenesis and Therapeutic Value

  2023cites this paper
• Insights into the function of HDAC3 and NCoR1/NCoR2 co-repressor complex in metabolic diseases

  2023cites this paper
• Adipose Tissue Dysfunction and Energy Balance Paradigms in People Living With HIV

  2023cites this paper
• The interplay between microbial metabolites and macrophages in cardiovascular diseases: A comprehensive review.

  2023cites this paper
• Short chain fatty acids: the messengers from down below

  2023cites this paper
• The Role of Gut Microbiome-Derived Short Chain Fatty Acid Butyrate in Hepatobiliary Diseases.

  2023cites this paper
• Gut microbiota induced epigenetic modifications in the non‐alcoholic fatty liver disease pathogenesis

  2023cites this paper
• Endocrine regulation of metabolic homeostasis via the intestine and gut microbiome.

  2023cites this paper
• Age-related effects of fenofibrate on the hepatic expression of sirtuin 1, sirtuin 3, and lipid metabolism-related genes.

  2023cites this paper
• Role of microbiota short-chain fatty acid chains in the pathogenesis of autoimmune diseases.

  2023cites this paper
• Butyrate and obesity: Current research status and future prospect

  2023cites this paper
• Bioactive Compounds as Inhibitors of Inflammation, Oxidative Stress and Metabolic Dysfunctions via Regulation of Cellular Redox Balance and Histone Acetylation State

  2023cites this paper
• Disturbance of lipid metabolism in germ-free mice transplanted with gut microbiota of DSS-induced colitis mice

  2023cites this paper
• Exploring the Epigenetic Regulated Modulation of Fibroblast Growth Factor 21 Involvement in High-Fat Diet Associated Parkinson's Disease in Rats.

  2023cites this paper
• Sodium butyrate and voluntary exercise through activating VEGF-A downstream signaling pathway improve heart angiogenesis in type 2 diabetes.

  2023cites this paper
• Sodium Propionate or Sodium Butyrate Promotes Fatty Acid Oxidation in HepG2 Cells Under Oxidative Stress

  2023cites this paper
• Gut Microbiota and Short Chain Fatty Acids: Implications in Glucose Homeostasis

  2022cites this paper
• Dietary Methionine via Dose-Dependent Inhibition of Short-Chain Fatty Acid Production Capacity Contributed to a Potential Risk of Cognitive Dysfunction in Mice.

  2022cites this paper
• Liver Brain Interactions: Focus on FGF21 a Systematic Review

  2022cites this paper
• Research Progress on Hypoglycemic Mechanisms of Resistant Starch: A Review

  2022cites this paper
• The enriched gut commensal Faeciroseburia intestinalis contributes to the anti-metabolic disorders effects of the Ganoderma meroterpene derivative

  2022cites this paper
• Safety of b-hydroxybutyrate salts as a novel food pursuant

  2022cites this paper
• Safety of β‐hydroxybutyrate salts as a novel food pursuant to Regulation (EU) 2015/2283

  2022cites this paper
• The Role of the Microbiota Gut–Liver Axis during HCV Chronic Infection: A Schematic Overview

  2022cites this paper
• Microbiota-derived short-chain fatty acids: Implications for cardiovascular and metabolic disease

  2022cites this paper
• β-Hydroxybutyrate upregulates FGF21 expression through inhibition of histone deacetylases in hepatocytes

  2022cites this paper
• Ketone Bodies and SIRT1, Synergic Epigenetic Regulators for Metabolic Health: A Narrative Review

  2022cites this paper
• Butyrate to combat obesity and obesity‐associated metabolic disorders: Current status and future implications for therapeutic use

  2022cites this paper
• Sodium butyrate ameliorates erectile dysfunction through fibrosis in a rat model of partial bladder outlet obstruction

  2022cites this paper
• HDAC1 overexpression promoted by METTL3-IGF2BP2 inhibits FGF21 expression in metabolic syndrome-related liver injury.

  2022cites this paper
• The Therapeutic Effect of SCFA-Mediated Regulation of the Intestinal Environment on Obesity

  2022cites this paper
• Butyrate, a typical product of gut microbiome, affects function of the AhR gene, being a possible agent of crosstalk between gut microbiome and hepatic drug metabolism.

  2022cites this paper
• Histone Deacetylases as Modulators of the Crosstalk Between Skeletal Muscle and Other Organs

  2022cites this paper
• Macronutrient Determinants of Obesity, Insulin Resistance and Metabolic Health

  2021cites this paper
• DMSO_A_317096 3281..3290

  2021cites this paper
• Sodium butyrate ameliorates Schistosoma japonicum-induced liver fibrosis by inhibiting HMGB1 expression.

  2021cites this paper
• Therapeutic Potential of Various Plant-Based Fibers to Improve Energy Homeostasis via the Gut Microbiota

  2021cites this paper
• Hepatic CPT1A Facilitates Liver-Adipose Cross-Talk via Induction of FGF21 in Mice.

  2021cites this paper
• Changes of Gut-Microbiota-Liver Axis in Hepatitis C Virus Infection

  2021cites this paper
• Advances in Biological Functions and Clinical Studies of FGF21

  2021cites this paper
• The Role of Fibroblast Growth Factor 21 in Diabetic Cardiovascular Complications and Related Epigenetic Mechanisms

  2021cites this paper
• Butyrate ameliorates alcoholic fatty liver disease via reducing endotoxemia and inhibiting liver gasdermin D-mediated pyroptosis

  2021cites this paper
• Tibet Kefir Milk Regulated Metabolic Changes Induced by High-Fat Diet via Amino Acids, Bile Acids, and Equol Metabolism in Human-Microbiota-Associated Rats.

  2021cites this paper
• High doses of butyrate induce a reversible body temperature drop through transient proton leak in mitochondria of brain neurons.

  2021cites this paper
• Butyrate Protects Endothelial Function Through PPARδ/miR-181b Signaling.

  2021cites this paper
• The relationship between gut microbiota, short-chain fatty acids and type 2 diabetes mellitus: the possible role of dietary fibre

  2021cites this paper
• Modulation of Short-Chain Fatty Acids as Potential Therapy Method for Type 2 Diabetes Mellitus

  2021cites this paper
• miR-22 inhibition reduces hepatic steatosis via FGF21 and FGFR1 induction

  2020cites this paper
• Keratinocyte aquaporin‐3 expression induced by histone deacetylase inhibitors is mediated in part by peroxisome proliferator‐activated receptors (PPARs)

  2020cites this paper
• Epigenetic Control of Mitochondrial Function in the Vasculature

  2020cites this paper
• Identification of novel cellular factors involved in HIV-1 latency

  2020cites this paper
• PPARα and NCOR/SMRT corepressor network in liver metabolic regulation

  2020cites this paper
• Sodium butyrate opens mitochondrial permeability transition pore (MPTP) to induce a proton leak in induction of cell apoptosis.

  2020cites this paper
• Role of ketogenic starvation sensors in mediating the renal protective effects of SGLT2 inhibitors in type 2 diabetes.

  2020cites this paper
• The autocrine role of FGF21 in cultured adipocytes.

  2020cites this paper
• Role of Microbiota in Pathogenesis and Management of Viral Hepatitis

  2020cites this paper
• Roles of Epigenetic Modifications in the Differentiation and Function of Pancreatic β-Cells

  2020cites this paper
• Herbal medicine of Kursi Wufarikun Ziyabit inhibits mitochondrial ATP production to activate AMPK in hepatocytes in therapy of type 2 diabetes

  2020cites this paper
• Bioactive Compounds for the Management of Hypertriglyceridemia: Evidence From Clinical Trials and Putative Action Targets

  2020cites this paper
• Prominent and emerging anti-diabetic molecular targets

  2020cites this paper
• Ketogenesis and SIRT1 as a tool in managing obesity.

  2020cites this paper
• Current understanding and controversies on the clinical implications of fibroblast growth factor 21

  2020cites this paper
• Super-dosed butyrate induces a revisable metabolic paralysis through transient mitochondrial reprogramming in the gut-brain axis

  2020cites this paper
• Sodium Propionate and Sodium Butyrate Promote Fatty Acid Oxidation in HepG2 Cells under Oxidative Stress

  2020cites this paper
• Lipid-regulating properties of butyric acid and 4-phenylbutyric acid: Molecular mechanisms and therapeutic applications.

  2019cites this paper
• Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice

  2019cites this paper
• WRKY18 and WRKY53 Coordinate with HISTONE ACETYLTRANSFERASE1 to Regulate Rapid Responses to Sugar1[OPEN]

  2019cites this paper